Form 8-K - Current report:
SEC Accession No. 0001437749-21-014909
Filing Date
2021-06-16
Accepted
2021-06-16 09:06:57
Documents
3
Period of Report
2021-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210615b_8k.htm 8-K 27289
2 EXHIBIT 99.1 ex_257658.htm EX-99.1 26650
3 a1.jpg GRAPHIC 11754
  Complete submission text file 0001437749-21-014909.txt   66019
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 211020578
SIC: 2834 Pharmaceutical Preparations